J&J Dumps Wrist Device IP To Clear Way For $21B Synthes Buy
Johnson & Johnson on Monday agreed to sell its patented system used to treat wrist fractures to Biomet Inc. in order to gain U.S. regulatory approval for its planned $21.3 billion...To view the full article, register now.
Already a subscriber? Click here to view full article